What Happens When Low-Trust Men Receive a Dose of Oxytocin?

Settling a 20-year scientific debate, groundbreaking international research reveals that the neuro-hormone specifically enhances cooperative behavior in individuals with low baseline trust.

For more than two decades, the precise role of oxytocin in shaping human social interactions and financial trust has remained a subject of intense scientific dispute. However, a landmark high-powered study published in August 2026 by an international research team—featuring behavioral economists from the University of Zurich, Otto von Guericke University Magdeburg, and the University of Antwerp—has provided definitive empirical evidence. Evaluating 359 male participants under strict experimental conditions, researchers demonstrated that intranasally administered oxytocin selectively increases trusting behavior among individuals with a low baseline disposition to trust, resolving years of inconsistent trial results and methodology debates.

Resolving Decades of Scientific Inconsistency

Following initial findings published in Nature in 2005 by a team led by University of Zurich professor Ernst Fehr, subsequent global replication attempts yielded mixed conclusions, often hindered by small sample sizes or varying experimental parameters. To address this skepticism, the current study utilized a pre-registered, high-powered design with 359 participants who were pre-screened and identified as having a low disposition to trust.

Key methodological and experimental findings documented in the study include:

• Controlled Blind Trials: Participants were randomly assigned to receive either an intranasal dose of oxytocin or a placebo spray under complete anonymity conditions.

• Standardized Trust Games: Subjects engaged in economic trust evaluations, deciding exact monetary amounts to entrust to anonymous counterparts.

• Measurable Behavioral Increases: Low-trusting participants who received oxytocin entrusted roughly 15% more money than those administered the placebo.

• Pooled Data Validation: Combining results with a prior compatible sample (totaling 578 low-trust individuals) revealed a statistically robust 16.9% increase in trusting behavior.

Selective Impact and Behavioral Implications

Crucially, the empirical data refutes the widespread assumption that oxytocin acts as a universal "prosocial booster" that makes all people indiscriminately trusting. Instead, the hormone's effects are highly selective, manifesting primarily among individuals who naturally exhibit skepticism or low baseline trust. Researchers noted that the degree of trust among high-trusting cohorts remained largely unaffected, often constrained by experimental ceiling effects. While the precise underlying biological mechanisms—such as whether the hormone dampens fear of betrayal or enhances cooperative expectations—require further exploration, the findings offer vital clarity for behavioral neurobiology and social psychology.

Why It Matters

Trust serves as the foundational bedrock of economic exchange, governance, and healthy social relationships. Understanding the neurobiological underpinnings of interpersonal trust helps researchers decode the complex biological drivers of human cooperation and social resilience.

Key Facts at a Glance

• Lead Research Institutions: University of Zurich, Otto von Guericke University Magdeburg, and University of Antwerp.

• Sample Size: 359 primary participants pre-screened for low dispositional trust (backed by pooled analysis totaling 578 subjects).

• Observed Effect: Roughly 15% to 16.9% increase in trusting behavior among low-trusting individuals.

• Publication Venue: Proceedings of the National Academy of Sciences (PNAS), August 2026.

FAQ Section

Does oxytocin make everyone more trusting of strangers?

No, the study demonstrates that oxytocin does not act as a universal prosocial booster; its effects are highly selective, increasing trust specifically in individuals with a low baseline disposition to trust.

How was the experiment conducted to measure trust?

Researchers administered intranasal oxytocin or a placebo to participants in a double-blind setup, who then engaged in an anonymous economic trust game involving financial allocations.

What was the magnitude of the trust increase observed in the study?

Participants with low baseline trust who received oxytocin exhibited a statistically significant 15% to 16.9% increase in trusting behavior compared to the placebo group.

Where can readers access the complete peer-reviewed study details?

The full research paper is accessible via the Proceedings of the National Academy of Sciences (PNAS) Journal Portal and summarized on the University of Zurich News Portal.

Source: University of Zurich News Portal, News-Medical Life Sciences Desk, Proceedings of the National Academy of Sciences (PNAS) Journal, BioRxiv Preprint Archives